SYNLOGIC, INC. — fact timeline

SYNLOGIC, INC. received a nasdaq delisting notice notice regarding other.

“January 16, 2026. As a result, on January 16, 2026, the Company received notice from Nasdaq that its shares will be suspended at the open of business on January 21, 2026. Nasdaq is expected to file a Form 25 Notification of Delisting with the Securities Exchange Commission when all internal procedural periods have run. The Company expects and plans for its shares of common stock to be quoted by the OTC Markets Group, Inc. (“OTC”) upon being delisted from Nasdaq. The Company will continue to remain a reporting company under the Securities Exchange Act of 1934, as amended, and the transition to”

SYNLOGIC, INC. received a nasdaq delisting notice notice regarding other.

“November 21, 2025, Synlogic, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that stated the Staff’s belief that the Company is a “public shell” and that, therefore, the continued listing of its securities is no longer warranted in the view of the Staff. In the Notice, the Staff explained that it based this belief on its review of the Company’s public disclosures and materials submitted to the Staff by the Company. In addition, the Staff noted its belief is supported by the Company’s lack o”

Michael Heffernan resigned as member of the board of directors at SYNLOGIC, INC..

“On February 20, 2025, Michael Heffernan tendered his resignation as a member of the board of directors (the “Board”) of Synlogic, Inc. (the “Company”) and as a member of the audit committee and nominating and governance committee of the Board, effective immediately.”

Nick Leschly resigned as Director at SYNLOGIC, INC..

“On January 10, 2025, Nick Leschly tendered his resignation as a member of the board of directors (the “Board”) of Synlogic, Inc. (the “Company”) and as a member of the compensation committee of the Board, effective immediately.”

SYNLOGIC, INC. reported the quarter ended March 31, 2024 results: revenue $0.01 million, net income consolidated net loss of $31.6 million, or $2.60 per share, EPS $2.60 per share.

“transaction. First Quarter 2024 Financial Results As of March 31, 2024 Synlogic had cash, cash equivalents, and short-term marketable securities of $32.3 million. Revenue was $0.01 million for the three months ended March 31, 2024, compared to $0.2 million for the corresponding period in 2023. Revenue for the three months ended March 31, 2024 was related to a”

Patricia N. Hurter resigned as Director at SYNLOGIC, INC..

“On March 20, 2024, Patricia N. Hurter, Ph.D. notified the Board of her decision to resi”

Lisa Kelly-Croswell resigned as Director at SYNLOGIC, INC..

“On March 20, 2024, Lisa Kelly-Croswell notified the Board of her decision to resign from the Board and the Compensation Committee as well as the Nominating and Governance Committee, effective immediately.”

Mike Burgess resigned as Director at SYNLOGIC, INC..

“On March 20, 2024, Mike Burgess, MB, CHB, Ph.D notified the Board of his decision to resign from the Board and the Audit Committee and the Science and Technology Committee, effective immediately.”

James Flynn was appointed as Class I Director at SYNLOGIC, INC..

“appointed James Flynn effective March 19, 2024 (the “Effective Date”), as a director to the Board to serve as a Class I Director”

SYNLOGIC, INC. reported the year ended December 31, 2023 results: revenue $3.4 million, net income $57.3 million, EPS $8.81 per share.

“$1.71 per share, compared to a consolidated net loss of $16.7 million, or $3.54 per share, for the corresponding period in 2022. Full Year 2023 Financial Results Revenues were $3.4 million for the year ended December 31, 2023, compared to $1.2 million for the same period in 2022. Revenue in both periods was associated with the research collaboration with Roche.”

SYNLOGIC, INC. reported the quarter ended December 31, 2023 results: revenue $2.8 million, net income $14.5 million, EPS $1.71 per share.

“Company. Fourth Quarter 2023 Financial Results As of December 31, 2023, Synlogic had cash, cash equivalents, and short-term marketable securities of $47.7 million. Revenue was $2.8 million for the three months ended December 31, 2023, compared to $0.1 million for the corresponding period in 2022. Revenue in both periods was associated with the research”